Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)-Reference-Cited by-同舟云学术

Incidence and Risk Factors of Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (3-Year Follow-Up of the j-Cypher Registry)

Published:2010-08 Issue:3 Volume:106 Page:329-336
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Nakagawa Yoshihisa,Kimura Takeshi,Morimoto Takeshi,Nomura Masanori,Saku Keijiro,Haruta Seiichi,Muramatsu Toshiya,Nobuyoshi Masakiyo,Kadota Kazushige,Fujita Hiroshi,Tatami Ryozo,Shiode Nobuo,Nishikawa Hideo,Shibata Yoshisato,Miyazaki Shunichi,Murata Yoshiharu,Honda Takashi,Kawasaki Tomohiro,Doi Osamu,Hiasa Yoshikazu,Hayashi Yasuhiko,Matsuzaki Masunori,Mitsudo Kazuaki

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome;Mehran;Circulation,1999

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

3. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

4. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II Trial;Claessen;Circ Cardiovasc Interv,2009

5. Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent;Wessely;Ann Intern Med,2005

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of statin therapy on late target lesion revascularization after everolimus-eluting stent implantation according to pre-interventional vessel remodeling and vessel size of treated lesion;Heart and Vessels;2022-06-20

2. Relationship between Lp-PLA2 and in-stent restenosis after coronary stenting: a 3-year follow-up study;Scottish Medical Journal;2021-07-28

3. Clinical Prognosis Associated With the Use of Overlapping Stents With Homogenous Versus Heterogeneous Pharmacological Characteristics for the Treatment of Diffuse Coronary Artery Disease;Cardiovascular Revascularization Medicine;2020-11

4. Effect of Glycemic Control During Follow-up on Late Target Lesion Revascularization After Implantation of New-Generation Drug-Eluting Stents in Patients With Diabetes　― A Single-Center Observational Study ―;Circulation Reports;2020-09-10

5. Multivariable prediction model to estimate the probability of restenosis at proximal edge after 2nd-generation drug-eluting-stent implantation: development and internal validation using a quantitative coronary angiography from the post-marketing surveillance studies of everolimus-eluting stent in Japan;Cardiovascular Intervention and Therapeutics;2020-04-18